Your session is about to expire
← Back to Search
Educational Program for Multiple Myeloma
Study Summary
This trial will test whether a structured educational program can improve quality of life for patients with multiple myeloma.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- People who have taken part in a different study for multiple myeloma that did not involve psychological or educational treatment can join this study.I have multiple myeloma but don't need systemic therapy.I have been diagnosed with MGUS or SMM.I can receive texts or emails for encouragement.I am 18 years old or older.I am only receiving care to make me comfortable in my final days.I have been diagnosed with multiple myeloma, either newly or it has returned.I don't have any health conditions that could risk my safety in the study.You are currently participating in a mental health education study for multiple myeloma.Currently receiving treatment through the UAB MM Clinic Pathway.Multiple myeloma patients who are not receiving treatment through the UAB Multiple Myeloma Clinic Pathway.I haven't had any other cancer in the last 3 to 5 years.
- Group 1: ARM B DELAYED INTERVENTION GROUP
- Group 2: ARM A EARLY INTERVENTION GROUP
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there currently an opportunity to join this medical research?
"The clinical trial's listing on clinicialtrials.gov confirms that it is not seeking participants at present, with the initial post date being November 27th 2017 and the most recent edit taking place on November 29th 2022. Despite this study's closure to enrollment, there are currently 807 studies actively recruiting subjects across multiple sites."
What objectives is this research endeavor trying to accomplish?
"As the primary outcome of this trial, over a Baseline time frame, investigators will measure MM patients’ levels of anxiety 24 weeks after completing an educational program (MPI) using the PROMIS assessment tool for Anxiety. Other indicators to be measured include baseline depression levels prior to implementation with the same instrument as well as 12 and 24-week postintervention evaluation of patient self-efficacy for symptom management and depression respectively."
Share this study with friends
Copy Link
Messenger